medigraphic.com
ISSN 1684-1824 (Electronic)

2013, Number 2

<< Back Next >>

Rev Méd Electrón 2013; 35 (2)

Pregnancy and usage of the folic acid as prevention for the neural tube defects

Rodríguez DPL, Collazo CI

Language: Spanish
References: 19
Page: 105-113
PDF size: 52.30 Kb.


ABSTRACT

Introduction: the defects of neural tube closing are serious brain and spinal column malformations. Periconceptional supplementation with folic acid, in adequate doses, has showed a reduction of these defects incidence.
Objective: to characterize pregnant women of the policlinic Milanes, municipality of Matanzas, and to describe their knowledge and usage of the folic acid before their pregnancy.
Methodology: cross-sectional descriptive study applied to 165 pregnant women from the health area José Jacinto Milanes of Matanzas, who answered a questionnaire to know their pregnancy characteristics and their knowledge and preventive usage of the folic acid.
Results: the average age was 24,2 years. 58,2 % of these women did not know the benefits of the folic acid to prevent the neural tube defects, and only 18,8 % used the drug before pregnancy. More than half of the interviewed women got pregnant unexpectedly, without planning it (54,5 %). There it was a poor assistance to the pre-conception consultation (9,1 %).
Conclusions: the preconception usage of the folic acid was low and the studied population was not conscious of the benefits of the preconception intake of this drug. Taking into account the high incidence of the non-planned pregnancy, it is recommended the folic acid supplementation to all the fertile aged women.


REFERENCES

  1. 1.Lumley L, Watson L, Watson M, Bower C. Preconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Sist Rev 2011. Citado en PubMed; PMID: 21491380.

  2. Obican SG, Finnell RH, Mill JL, Shaw GM, Scialli AR. Folic Acid in early pregnancy: a public health success story. FASEB J. 2010; 24(1): 4167-74. Citado en PubMed; PMID:20631328.

  3. Ortega García JA, Ferris Tortajada J, Claudio L, Soldin OP, Sánchez Sauco MF, Fuster Soler JL, et al. Case control study of periconceptional folic acid intake and nervous system tumors in children. Childs Nerv Syst. 2010; 26(12): 1727-33. Citado en PubMed; PMID:20496070

  4. Bergen N, Jaddoe V, Timmermans S, Hofman A, Lindemans J, Raat H, et al. Homocysteine and folate concentration in early pregnancy an the risk of adverse pregnancy outcome: the Generation R Study. BJOG. 2012; 119(6): 739-51. Citado en PubMed; PMID:22489763

  5. De Regil LM, Fernández Gaxiola AC, Dowswell T, Peña Rosas JP. Effects and safety periconceptional folate supplementation for preventing birth defects. Cochrane Database of Sistematic Review, Issue o1, 2012 (Status in this issue NEW). DOI: 10.1002/14651858.pub10. Citado en PubMed; PMID :20927767

  6. Harden CL, Pennel PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ, et al. Management issues with epilepsy-focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breast-feeding. Report of the Quality Standards Sybcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009; 50(5): 1247-55. Citado en PubMed; PMID:19507305.

  7. Baykan Z, Ozturk A, Poyrazoghi S, Gün I. Awareness, knowledge and use of folic acid among women: a study from Turkey. Arch Gynecol Obstet. 2011; 283(6): 1249-53. Citado en PubMed; PMID: 20552211

  8. Nasr Hage C, Jalloul M, Sabbah M, Adib SM. Awareness and intake of folic acid for the prevention of neural tube defects among Lebanese women of childbearing age. Matern Child J. 2012; 16(1): 258-65. Citado en PubMed; PMID: 21210201.

  9. Zabala R, Waisman I, Correlli M, Tobler B, Bonora L, Cappato F. Folic acid for neural tube defects prevention: consumption and information in fertil-age women in Centro Cuyo Region. Arch Argent Pediatr. 2008; 106(4): 295-301. Citado en PubMed; PMID: 18766275

  10. Wilton DC, Foureur MJ. A survey of folic acid in primigravid women. Women Birth. 2010; 23(2): 67-73. Citado en PubMed; PMID:19828392

  11. Jou HJ, Hsu IP, Liu CY, Chung SH, Chen SM, Gau ML. Awareness and use folic acid among pregnant women in Taipei. Taiwan J Obstet Gynecol. 2010; 49(3): 306-10. Citado en PubMed; PMID: 21056316.

  12. Tam LE, Mc Donald SD, Wen SW, Smith GM, Windrim RC, Walker MC. A survey of preconceptional folic acid use in a group of canadian women. J Obstetric Gynaecol. 2005: 27(3): 232-6. Citado en PubMed; PMID: 15937596.

  13. Tamin H, Harrison G, Atoni M, Mumtaz G, El-Kak F, Seoud M, et al. Preconceptional folic acid supplements use in Lebanon. Public Health Nutr. 2009; 12(5): 687-92. Citado en PubMed; PMID:18616852.

  14. Meiksin R, Chang JC, Bhargava T, Arnold R, Dado D, Frankel R, et al. Now is the chance: patien-provider communication about unplanned pregnancy during the first prenatal visit. Patien Educ Couns. 2010; 81(3): 462-7. Citado en PubMed; PMID: 20884161

  15. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities. Contraception. 2011; 84(5): 478-85. Citado en PubMed; PMID: 22018121.

  16. Prietsch SO, González Chica DA, Cesar JA, Mendoza Sassi RA. Unplanned pregnancy in Southern Brazil, prevalence and associated factors. Cad Saude Public. 2011; 27(10): 1006-6. Citado en PubMed; PMID: 22031195.

  17. Karacam Z, Onel K, Gercek E. Effects or unplanned pregnancy on maternal health in Turkey. Midwifery. 2011; 27(2): 288-93. Citado en PubMed; PMID:19773101.

  18. Hearton L. Using Action Reversible Contraception to avoid unplanned pregnancy. Nurs Times. 2012; 108(8): 22-4.Citado en PubMed; PMID: 22458082.

  19. Fernández Ramos H, Crespo Estrada Y, Estrada Astral IL, Rodríguez Gutiérrez K. Impacto de una estrategia de intervención comunitaria sobre el control del riesgo reproductivo preconcepcional. AMC[Internet]. 2008[citado 24 Nov 2012]; 12(3). Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552008000300007




2020     |     www.medigraphic.com